Get Our Free Research Email
Conference Calendar 
May 17-19 - 2012 AANA Annual Meeting
May 20-23 - Current Concepts in Joint Replacement Spring 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
August 2003
Max Link, Centerpulse’s CEO, could get severance pay of nearly five million Swiss francs ($3.53 million) if he leaves the firm within a year of Zimmer's takeover. (Centerpulse, by the way, has declared that its recommendation to shareholders to vote... more
Apparently “off-label” is a “no-no” if you're a U.S. military physician. Orthofix fought for a while, then settled. Last week, Orthofix decided it was better off avoiding the costs of a protracted litigation battle with the government and opted to... more
For the June quarter, Orthovita reported a 37% YOY jump in sales to $3.7 million. Gross margins were a stellar 83%. But losses for the quarter came in at $2.3 million (down from the prior year's $3.0 million loss for... more
Is anyone paying attention to Biomet? With Stryker at 38x earnings, Zimmer at 31x earnings and little ol' Wright Medical (3% market share) at a whopping 48x earnings, why is Biomet at 26x? Those, by the way, are trailing 12... more
DJ Ortho reported a sharp increase in net earnings to $2.7 million ($0.15 per share) on just a 4% rise in sales to $47 million for the June quarter. Operating margins improved significantly in the quarter reaching 15% of sales.... more
CryoLife reported a loss of $22.3 million on sales of $15.7 million for the quarter ended June 30. Orthopedic sales, which amounted to $280,000, were less than we'd expected and appear to have been delayed from management's earlier forecasts. But... more
To our surprise, as well as most of the analyst on Wall Street, Smith & Nephew publicly announced its decision not to up its current offer of approximately $2.5 billion in order to triumph Zimmer Holdings approximate $3.1 billion offer.... more
Based on the dynamic duo of demographics and technological innovation (specifically disc arthroplasty and minimally invasive surgical tools and techniques) spine industry revenues will, we estimate, rise from $2 billion currently to $7.2 billion by 2012. Who will be the... more
Rejected one year ago... Medtronic came back with new data and CMS, while rejecting InFuse again using one analytical approach found another way to show that InFUSE does indeed meet the threshold requirement for receiving a new technology add-on payment.... more
See you at the Summit!! It's been an extraordinary year for the Spine industry. CMS finally approved an add-on payment for InFUSE™. Just a few months ago Spine Solutions, a development stage company, sold to Synthes for $350 million. Link... more
Complete Archive
|
